Collegium Pharmaceutical (COLL) Raw Materials (2016 - 2025)

Collegium Pharmaceutical's Raw Materials history runs 10 years deep, the most recent figure standing at $8.3 million for Q3 2025.

• In Q3 2025, Raw Materials rose 98.31% year-over-year to $8.3 million; the TTM figure through Sep 2025 stood at $8.3 million (up 98.31% YoY), while the FY2024 annual figure was $12.5 million, up 20.68% from the prior year.
• Raw Materials was $8.3 million for Q3 2025 at Collegium Pharmaceutical, down from $9.5 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $14.4 million in Q3 2023 to a low of $3.7 million in Q4 2021.
• Historically, Raw Materials has averaged $7.7 million across 5 years, with a median of $7.2 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Raw Materials soared 149.84% in 2023, then slumped 70.8% in 2024.
• A 5-year view of Raw Materials shows it stood at $3.7 million in 2021, then surged by 51.97% to $5.6 million in 2022, then jumped by 85.43% to $10.4 million in 2023, then advanced by 20.68% to $12.5 million in 2024, then slumped by 33.48% to $8.3 million in 2025.
• The last three Raw Materials figures came in at $8.3 million (Q3 2025), $9.5 million (Q2 2025), and $11.8 million (Q1 2025), per Business Quant data.